icer glp 1 Incremental cost-effectiveness ratio (ICER) scatterplot comparing newer Should People Who Want GLP-1s
Description
Piccinini-Vallis H, Woolcott C, Miller L, Snelgrove-Clarke E, Cahill S
Both are sold by Danish drug giant Novo Nordisk
Novikoff A, O'Brien SL, Bernecker M, Grandl G, Kleinert M, Knerr PJ, et al
Finally, although our meta-analysis showed that GLP-1 receptor agonists increased the risk of overall thyroid disorder, due to the decrease in sample size, it did not show statistically significant results for specific thyroid disorder
